SCHEMBL17015776

SCHEMBL17015776

O=C(c1ccccc1)c1cccc(-n2c3ccccc3c3ccc4c(ccn4-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c32)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.36
FOLH1 Q04609 1/20 0.35
SETD7 Q8WTS6 1/20 0.35
EHMT2 Q96KQ7 1/20 0.35
CYP19A1 P11511 1/20 0.35
RORC P51449 1/20 0.35
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
ALDH1A1 P00352 3/20 0.34
GLA P06280 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 3/20 0.34
PKM P14618 1/20 0.34
CNR1 P21554 2/20 0.33
WNK1 Q9H4A3 1/20 0.32
HPGD P15428 1/20 0.32
KMO O15229 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015695 0.93 CYP19A1 (0.38) CNR2FOLH1SETD7EHMT2CYP19A1
SCHEMBL17015771 0.93 CNR2 (0.36) CNR2CYP19A1RORCATML3MBTL1
SCHEMBL17015779 0.92 CLK1 (0.36) CNR2FOLH1SETD7EHMT2CYP19A1
SCHEMBL17015225 0.91 CNR2 (0.40) CNR2FOLH1SETD7EHMT2RORC
SCHEMBL17016181 0.89 RORC (0.41) CNR2FOLH1SETD7EHMT2RORC
SCHEMBL17015785 0.88 L3MBTL1 (0.41) ATML3MBTL1ALDH1A1KDM4EWNK1
SCHEMBL17015774 0.87 CNR2 (0.35) CNR2ALDH1A1GLASMN1; SMN2KDM4E
SCHEMBL20408510 0.87 ATM (0.38) ATML3MBTL1ALDH1A1KDM4EPKM
SCHEMBL16613857 0.87 L3MBTL1 (0.44) ATML3MBTL1ALDH1A1KDM4EWNK1
SCHEMBL17015745 0.86 KDM4E (0.36) ATML3MBTL1KDM4EWNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 CNR2 1583/4885FOLH1 3496/4885SETD7 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.